For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Samumed, LLC

USPTO Granted Patents = 115

% Expired Patents = 2.6

CIPO Patents = 4

EPO Patents = 15

Trademarks = 1

Forward Citations = 2,502

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Sunil Kumar Kc (106 out of 125 patents)

John Hood (96 out of 123 patents)

David Mark Wallace (86 out of 119 patents)

4. Chandramouli Chiruta (53 out of 58 patents)

5. Jianguo Cao (53 out of 84 patents)

6. Gopi Kumar Mittapalli (17 out of 24 patents)

7. Chi Ching Mak (16 out of 34 patents)

8. Venkataiah Bollu (15 out of 26 patents)

9. Charlene F Barroga (13 out of 16 patents)

10. Brian Walter Eastman (13 out of 34 patents)

11. Brian Joseph Hofilena (10 out of 15 patents)

12. Joseph Timothy Marakovits (7 out of 20 patents)

13. Sunil Kumar K C (7 out of 23 patents)

14. Luis A Dellamary (4 out of 77 patents)

15. Yusuf Yazici (3 out of 5 patents)

Core Competencies:

Wnt Signaling

Indazole Inhibitors

Gamma-Diketones

Osteoarthritis Treatment

Carboxamides

Therapeutic Uses

Anti-Inflammatory

Injectable Formulations

115 patents: Sort by Forward Citations

1. 11034682 - Gamma-diketones as wnt/β-catenin signaling pathway activators (2021-06-15),

2. 10981909 - Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide (2021-04-20),

3. 10947228 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof (2021-03-16),

4. 10947217 - Isoquinolin-3-YL carboxamides and preparation and use thereof (2021-03-16),

5. 10934297 - 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof (2021-03-02),

6. 10899757 - 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof (2021-01-26),

7. 10882860 - Treatment of osteoarthritis (2021-01-05),

8. 10806726 - Methods of using indazole-3-carb oxamides and their use as Wnt/B-catenin signaling pathway inhibitors (2020-10-20),

9. 10759799 - Indazole containing macrocycles and therapeutic uses thereof (2020-09-01),

10. 10758523 - Single-dose, ready-to-use injectable formulations (2020-09-01),

11. 10744128 - 6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof (2020-08-18),

12. 10703748 - Diazanaphthalen-3-yl carboxamides and preparation and use thereof (2020-07-07),

13. 10669240 - 5-substituted indazole-3-carboxamides and preparation and use thereof (2020-06-02),

14. 10654832 - 3-(benzoimidazol-2-YL)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof (2020-05-19),

15. 10653688 - 6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof (2020-05-19),

Company Overview

Samumed, LLC is a biotechnology company based in San Diego, California, specializing in the development of innovative therapies targeting the Wnt signaling pathway. The company focuses on advancing treatments for various conditions, including osteoarthritis, through its proprietary technologies involving indazole inhibitors and gamma-diketones. Samumed's research emphasizes anti-inflammatory applications and injectable formulations, aiming to address unmet medical needs and improve patient outcomes in therapeutic areas influenced by Wnt signaling.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

115 Patents

#50 in San Diego, CA

#755 in California

#3,343 in US

#6,898 in the World

San Diego, CA, United States of America

Samumed, LLC

Forward Citations = 2,502

19 inventors:

Sunil Kumar Kc (106 out of 125 patents)

John Hood (96 out of 123 patents)

David Mark Wallace (86 out of 119 patents)

4. Chandramouli Chiruta (53 out of 58 patents)

5. Jianguo Cao (53 out of 84 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Samumed, LLC. Retrieved from https://idiyas.com/company/samumed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…